Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial

Clinical Pediatrics

Volumn 48, Issue 7, 2009, Pages 734-744

  Scalabrin, Deolinda M ^a   Johnston, William H ^b   Hoffman, Dennis R ^c   P'Pool, Virginia L ^a   Harris, Cheryl L ^a   Mitmesser, Susan H ^a  

^a Mead Johnson Nutrition ^*  (United States)

^b Birmingham Radiological Group PC   (United States)

^c RETINA FOUNDATION OF THE SOUTHWEST   (United States)

Author keywords

Allergy; Extensively hydrolyzed formula; Infant formula; Infant growth; LGG; Partially hydrolyzed formula; Polyunsaturated fatty acids

Indexed keywords

CASEIN; IMMUNOGLOBULIN E; PROBIOTIC AGENT;

ALLERGIC REACTION; ARTICLE; ARTIFICIAL MILK; BOTTLE FEEDING; CHILD GROWTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; GROWTH RATE; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LACTOBACILLUS RHAMNOSUS; NORMAL HUMAN; WHEY;

BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; FATTY ACIDS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; MALE; MILK HYPERSENSITIVITY; PROBIOTICS; PROSPECTIVE STUDIES;

EID: 68949131201     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922809332682     Document Type: Article

References (41)

1. Fuller R. Probiotics in human medicine. Gut. 1991;32:439-442.
2. Gorbach SL The discovery of Lactobacillus GG. Nutr Today. 1996;31(6):2S-3S.
3. Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr. 1997;25:516-519.
4. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564-568.
5. Petschow BW, Figueroa R, Harris CL, Beck LB, Ziegler E, Goldin B. Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants. J Clin Gastroenterol. 2005;39:786-790.
6. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179-185.
7. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604-1610.
8. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60:494-500.
9. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019-1021.
10. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology. 1993;105:1643-1650.
11. Isolauri E, Kaila M, Mykkanen H, Ling WH, Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci. 1994;39:2595-2600.
12. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141-144.
13. Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000;30:1804-1808.
14. Di Caro S, Tao H, Grillo A, et al. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis. 2005;37:320-329.
15. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2006;117(suppl 2):S470-S475.
16. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259-1260.
17. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet. 1999;353:196-200.
18. Erb KJ. Atopic disorders: a default pathway in the absence of infection? Immunol Today. 1999;20:317-322.
19. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol. 1998;160:4730-4737.
20. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108:144-145.
21. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129-134.
22. Sampson HA Food allergy. J Allergy Clin Immunol. 2003;111(2 suppl):S540-S547.
23. Høst A, Koletzko B, Dreborg S, et al. Dietary products used in infants for treatment and prevention of food allergy. Joint statement of the ESPACI Committee on Hypoallergenic Formulas and the ESPGHAN Committee on Nutrition. Arch Dis Childhood. 1999;81:80-84.
24. American Academy of Pediatrics: Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics. 2000;106(2, pt 1):346-349.
25. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007;85:1457-1464.
26. Koletzko B, Thiel I, Abiodun PO The fatty acid composition of human milk in Europe and Africa. J Pediatr. 1992;120(4, pt 2):S62-S70.
27. Hoffman DR, Wheaton DKH, James KJ, et al. Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr. 2006;42:287-292.
28. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45-60.
29. Needleman R. Growth and development. In: Berhman R, Kliegman R, Jensen H, eds. Nelson Textbook of Pediatrics. Philadelphia, PA: W. B. Saunders; 2004:23-66.
30. Finberg L, Bell EF, Cooke RJ, et al. American Academy of Pediatrics Task Force on Clinical Testing of Infant Formulas: Clinical Testing of Infant Formulas With Respect to Nutritional Suitability for Term Infants. Rockville, MD: US Food and Drug Administration, Center for Food Safety and Applied Nutrition; 1988.
31. Vendt N, Grunberg H, Tuure T, et al. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet. 2006;19:51-58.
32. Laitinen K, Kalliomaki M, Poussa T, Lagstrom H, Isolauri E. Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years. Br J Nutr. 2005;94:565-574.
33. Hyams JS, Treem WR, Etienne NL, et al. Effect of infant formula on stool characteristics of young infants. Pediatrics. 1995;95:50-54.
34. Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553.
35. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.
36. Morale SE, Hoffman DR, Castañeda YS, Wheaton DH, Burns RA, Birch EE. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81:197-203.
37. Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev. 2007;83:279-284.
38. Kankaanpää PE, Yang B, Kallio HP, Isolauri E, Salminen SJ. Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants. J Nutr Biochem. 2002;13:364-369.
39. West CE, Gothefors L, Granstrom M, Kayhty H, Hammarstrom ML, Hernell O. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol. 2008;19:53-60.
40. Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy: a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol. 2006;17:416-421.
41. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16:1907-1916.